{
  "id": 11504681,
  "title": "Geographic atrophy biotech Aviceda to shut down after Phase 2 fail",
  "url": "https://urgent.news/2026/10/02/geographic-atrophy-biotech-aviceda-to-shut-down-after-phase-2-fail",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-02T18:36:17.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/geographic-atrophy-biotech-aviceda-to-shut-down-after-phase-2-fail/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Aviceda Therapeutics, a biotech that had planned to take an eye drug into Phase 3 this year despite a mid-stage clinical setback, is in the process of winding down, a source familiar with the decision ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}